Table 2 Prevalence of EGF genotypes and allele frequencies among melanoma and non-melanoma subjects.
Genotype | Healthy controls (%) | Melanoma patients (%) | Odds ratio* (95% CI) |
|---|---|---|---|
A/A | 93 (36.5%) | 144 (34.4%) | 1.00 |
A/G | 117 (45.9%) | 206 (49.3%) | 1.13 (0.57–2.11) |
G/G | 45 (17.6%) | 68 (16.3%) | 0.89 (0.29–1.63) |
Total cases | 255 | 418 | Â |
Allele | Â | Â | Â |
A | 303 (60%) | 494 (59%) | 1.00 |
G | 207 (40%) | 342 (41%) | 1.04 (0.39–1.97) |